Urinary deoxypyridinoline, serum osteocalcin and bone mineral density in girls with Turner's syndrome.
Department of Endocrinology for Children and Adolescents, University of Medicine, Wroclaw, Poland. wikierab@wp.pl
Beata
B
Wikiera
Zdzislawa
Z
Iwanicka
Ewa
E
Barg
Ewa
E
Serafinowicz
D000293:Adolescent; D000375:Aging; D000596:Amino Acids / Q000652:urine*; D015992:Body Mass Index; D015519:Bone Density / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D041321:Chromosomes, Human, X / Q000235:genetics; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007621:Karyotyping / Q000379:methods; D015675:Osteocalcin / Q000097:blood*; D011044:Poland; D013997:Time Factors; D014424:Turner Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics
D000596:Amino Acids; D015675:Osteocalcin; D019382:Human Growth Hormone; C036020:deoxypyridinoline